ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,434Medicare Part D Prescriptions Filled, Including Refills
$462K Total Retail Price of All Prescriptions
364 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 504 465
FUROSEMIDE 487 471
POTASSIUM CHLORIDE 386 355
LEVOTHYROXINE SODIUM 371 364
WARFARIN SODIUM 362 362
OMEPRAZOLE 313 289
LISINOPRIL 265 245
HYDROCODONE-ACETAMINOPHEN 262 233 S3
TRIAMTERENE-HCTZ 213 213
METOPROLOL TARTRATE 212 210
METFORMIN HCL 198 178
AMLODIPINE BESYLATE 174 172
ALLOPURINOL 173 161
METOPROLOL SUCCINATE 165 165
DONEPEZIL HCL 158 158
GABAPENTIN 137 120
TAMSULOSIN HCL 136 126
CARVEDILOL 120 120
CITALOPRAM HBR 117 104
TRAMADOL HCL 106 81
NAMENDA 95 95
POLYETHYLENE GLYCOL 3350 95 92
FENTANYL 95 34 S2
AZITHROMYCIN 87 80
OXYCODONE-ACETAMINOPHEN 86 79 S2
TRIAMTERENE-HYDROCHLOROTHIAZID 86 86
LANTUS 85 75
SERTRALINE HCL 83 66
TRAZODONE HCL 82 70
QUETIAPINE FUMARATE 80 80
GLIPIZIDE 78 78
PREDNISONE 74 63
ALENDRONATE SODIUM 70 70
ESCITALOPRAM OXALATE 68 66
HYDROCHLOROTHIAZIDE 65 65
MELOXICAM 62 60
HUMULIN 70-30 61 52
PRAVASTATIN SODIUM 60 60
TRIAMCINOLONE ACETONIDE 60 60
CEPHALEXIN 59 54
FLUTICASONE PROPIONATE 58 58
CELEBREX 58 57
VENLAFAXINE HCL ER 57 57
GEMFIBROZIL 56 54
ZOLPIDEM TARTRATE 56 43
CYMBALTA 54 51
LOSARTAN POTASSIUM 52 48
CLOTRIMAZOLE-BETAMETHASONE 50 46
CRESTOR 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.